Jane Ennis

407 total citations
18 papers, 286 citations indexed

About

Jane Ennis is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Jane Ennis has authored 18 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 9 papers in Public Health, Environmental and Occupational Health and 4 papers in Epidemiology. Recurrent topics in Jane Ennis's work include Viral Infections and Vectors (11 papers), Mosquito-borne diseases and control (9 papers) and Viral Infections and Outbreaks Research (7 papers). Jane Ennis is often cited by papers focused on Viral Infections and Vectors (11 papers), Mosquito-borne diseases and control (9 papers) and Viral Infections and Outbreaks Research (7 papers). Jane Ennis collaborates with scholars based in United States, Canada and United Kingdom. Jane Ennis's co-authors include Jeffrey D. Turner, Justin G. Julander, John D. Morrey, Brian B. Gowen, Larry Zeitlin, Min‐Hui Wong, Eric J. Sefing, Xiangguo Qiu, Gary Wong and Justin Jang Hann Chu and has published in prestigious journals such as PLoS ONE, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Jane Ennis

18 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Ennis United States 13 184 97 68 61 48 18 286
Amanda Phelps United Kingdom 11 169 0.9× 76 0.8× 91 1.3× 41 0.7× 88 1.8× 24 299
Isabel García-Dorival United Kingdom 11 249 1.4× 50 0.5× 78 1.1× 46 0.8× 70 1.5× 20 362
Bersabeh Tigabu United States 11 376 2.0× 109 1.1× 109 1.6× 74 1.2× 81 1.7× 18 487
Emilio Ortiz-Riaño United States 11 343 1.9× 63 0.6× 184 2.7× 114 1.9× 132 2.8× 15 561
Lorena Sánchez-Felipe Belgium 9 149 0.8× 57 0.6× 104 1.5× 40 0.7× 88 1.8× 15 336
Jesse Steffens United States 11 191 1.0× 30 0.3× 80 1.2× 74 1.2× 67 1.4× 15 297
Erik Dietzel Germany 13 287 1.6× 47 0.5× 259 3.8× 57 0.9× 105 2.2× 20 470
Jill Oldenburg United States 10 299 1.6× 102 1.1× 149 2.2× 89 1.5× 73 1.5× 10 487
Aldo Barrera Chile 9 90 0.5× 23 0.2× 177 2.6× 57 0.9× 121 2.5× 12 337
Laure R. Deflubé United States 9 242 1.3× 18 0.2× 169 2.5× 31 0.5× 62 1.3× 9 342

Countries citing papers authored by Jane Ennis

Since Specialization
Citations

This map shows the geographic impact of Jane Ennis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Ennis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Ennis more than expected).

Fields of papers citing papers by Jane Ennis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Ennis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Ennis. The network helps show where Jane Ennis may publish in the future.

Co-authorship network of co-authors of Jane Ennis

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Ennis. A scholar is included among the top collaborators of Jane Ennis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Ennis. Jane Ennis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Phelps, Amanda, Lyn M. O’Brien, David Ulaeto, et al.. (2021). Cross-Strain Neutralizing and Protective Monoclonal Antibodies against EEEV or WEEV. Viruses. 13(11). 2231–2231. 3 indexed citations
2.
Burke, Crystal W., Franco Rossi, Crystal L. Moyer, et al.. (2019). Therapeutic monoclonal antibody treatment protects nonhuman primates from severe Venezuelan equine encephalitis virus disease after aerosol exposure. PLoS Pathogens. 15(12). e1008157–e1008157. 25 indexed citations
3.
Phelps, Amanda, Lyn M. O’Brien, Lin Eastaugh, et al.. (2019). Aerosol infection of Balb/c mice with eastern equine encephalitis virus; susceptibility and lethality. Virology Journal. 16(1). 2–2. 17 indexed citations
4.
Verreault, Daniel, Jane Ennis, Kevin J. Whaley, et al.. (2019). Effective Treatment of Staphylococcal Enterotoxin B Aerosol Intoxication in Rhesus Macaques by Using Two Parenterally Administered High-Affinity Monoclonal Antibodies. Antimicrobial Agents and Chemotherapy. 63(5). 15 indexed citations
5.
Phelps, Amanda, Lyn M. O’Brien, Lin Eastaugh, et al.. (2017). Susceptibility and Lethality of Western Equine Encephalitis Virus in Balb/c Mice When Infected by the Aerosol Route. Viruses. 9(7). 163–163. 12 indexed citations
6.
Pettit, Dean K., Richard S. Rogers, Kelly K. Arthur, et al.. (2016). CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody. mAbs. 8(2). 347–357. 17 indexed citations
7.
Ennis, Jane, et al.. (2016). Single dose of an adenovirus vectored mouse interferon-α protects mice from lethal EV71 challenge. Antiviral Research. 134. 207–215. 15 indexed citations
8.
Wong, Gary, Jason S. Richardson, Stéphane Pillet, et al.. (2015). Adenovirus-Vectored Vaccine Provides Postexposure Protection to Ebola Virus–Infected Nonhuman Primates. The Journal of Infectious Diseases. 212(suppl 2). S379–S383. 14 indexed citations
9.
10.
Damjanovic, Daniela, Maria Fe C. Medina, Jane Ennis, et al.. (2014). Type 1 interferon gene transfer enhances host defense against pulmonary Streptococcus pneumoniae infection via activating innate leukocytes. Molecular Therapy — Methods & Clinical Development. 1. 5–5. 20 indexed citations
11.
Gowen, Brian B., Jane Ennis, Kevin W. Bailey, et al.. (2014). Single-Dose Intranasal Treatment with DEF201 (Adenovirus Vectored Consensus Interferon) Prevents Lethal Disease Due to Rift Valley Fever Virus Challenge. Viruses. 6(3). 1410–1423. 9 indexed citations
12.
Smee, Donald F., Min‐Hui Wong, Brett L. Hurst, Jane Ennis, & Jeffrey D. Turner. (2013). Effects of Nasal or Pulmonary Delivered Treatments with an Adenovirus Vectored Interferon (mDEF201) on Respiratory and Systemic Infections in Mice Caused by Cowpox and Vaccinia Viruses. PLoS ONE. 8(7). e68685–e68685. 4 indexed citations
13.
Qiu, Xiangguo, Gary Wong, Lisa Fernando, et al.. (2013). Monoclonal Antibodies Combined with Adenovirus-Vectored Interferon Significantly Extend the Treatment Window in Ebola Virus-Infected Guinea Pigs. Journal of Virology. 87(13). 7754–7757. 25 indexed citations
14.
Gowen, Brian B., Jane Ennis, Eric J. Sefing, et al.. (2012). Extended Protection against Phlebovirus Infection Conferred by Recombinant Adenovirus Expressing Consensus Interferon (DEF201). Antimicrobial Agents and Chemotherapy. 56(8). 4168–4174. 10 indexed citations
15.
Gowen, Brian B., Jane Ennis, Andrew Russell, et al.. (2011). Use of Recombinant Adenovirus Vectored Consensus IFN-α to Avert Severe Arenavirus Infection. PLoS ONE. 6(10). e26072–e26072. 16 indexed citations
16.
Smee, Donald F., Min‐Hui Wong, Andrew T. Russell, Jane Ennis, & Jeffrey D. Turner. (2011). Therapy and Long-Term Prophylaxis of Vaccinia Virus Respiratory Infections in Mice with an Adenovirus-Vectored Interferon Alpha (mDEF201). PLoS ONE. 6(10). e26330–e26330. 7 indexed citations
17.
Julander, Justin G., Jane Ennis, Jeffrey D. Turner, & John D. Morrey. (2011). Treatment of Yellow Fever Virus with an Adenovirus-Vectored Interferon, DEF201, in a Hamster Model. Antimicrobial Agents and Chemotherapy. 55(5). 2067–2073. 30 indexed citations
18.
Kumaki, Yohichi, Jane Ennis, Ramtin Rahbar, et al.. (2010). Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model. Antiviral Research. 89(1). 75–82. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amanda Phelps Breakdown of academic impact, for papers by Isabel García-Dorival Breakdown of academic impact, for papers by Bersabeh Tigabu Breakdown of academic impact, for papers by Emilio Ortiz-Riaño Breakdown of academic impact, for papers by Lorena Sánchez-Felipe Breakdown of academic impact, for papers by Jesse Steffens Breakdown of academic impact, for papers by Erik Dietzel Breakdown of academic impact, for papers by Jill Oldenburg Breakdown of academic impact, for papers by Aldo Barrera Breakdown of academic impact, for papers by Laure R. Deflubé
Rankless by CCL
2026